Condition: Transcatheter Aortic Valve Implantation (TAVI) · Aortic Valve Stenosis · Transcatheter Aortic Valve Replacement · Sponsor: Transverse Medical, Inc.
The purpose of this study is to assess the feasibility and safety of the Transverse Medical, Inc. Point-Guard device. This feasibility study is a limited clinical investigation of the Point-Guard device. The study will be conducted to evaluate the device design concept with respect to clinical safety and device functionality.
This description comes directly from the study's public registry record.
Erin Spiegel, PhD · +13033252945 · erin.spiegel@transversemedical.com
Blair Holman · +13033252945 · blair.holman@transversemedical.com
Always discuss trial participation with your own doctor first.
| Victorian Heart Hospital | Clayton, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06962371